Alumni raised $1.45B in 2022 - Download Free Report Now

Orchestra BioMed

Congratulations to Orchestra BioMed on being selected as an Innovation Leader at LSI’s Emerging Medtech Summit 2020.

Purchase 2020 Summit (digital) Get info on 2021 Summit (in-person)
David

David Hochman

CEO, Founder & Chairman of the Board of Directors

Orchestra BioMed

Multi-asset portfolio of therapeutic solutions for cardiovascular disease, hypertension and other indications

Share

Coming Soon

Our Clients

0-Minnetronix.png
1-jnj.png
2-medtronic.png
3-abbott.png
4-baxter.png
5-mckinsey.png
7-bostonscientific.png
8-bd.png
9-smithnephew.png
10-stryker.png
33m.png
allergan.png
bbraun.png
beckmancoulter.png
cardinal.png
depuysynthes.png
drager.png
edwardslifesciences.png
ethicon.png
ge.png
gore.png
health-advances.png
hospira.png
jlabs.png
kimberlyclark.png
merck.png
olympus.png
orthofix.png
philips.png
sanofigenzyme.png
tecan.png
teleflex.png
terumo.png
zimmerbiomet.png